StockNews.com Begins Coverage on Avinger (NASDAQ:AVGR)

by · The Cerbat Gem

Analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a report issued on Monday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Shares of AVGR stock opened at $0.47 on Monday. The stock’s 50 day simple moving average is $0.56 and its 200 day simple moving average is $0.79. Avinger has a twelve month low of $0.36 and a twelve month high of $4.37. The company has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Featured Stories